1887

Chapter 12 : Discovering What You Do and Don't Want

Editor: Ronald M. Atlas1
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Department of Biology, University of Louisville, Louisville, Kentucky
Content Type: Trade
Publication Year: 2000

Category: History of Science

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Discovering What You Do and Don't Want, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap12-1.gif /docserver/preview/fulltext/10.1128/9781555818128/9781555811907_Chap12-2.gif

Abstract:

Michael A. Pfaller continued to pursue applied research in terms of evaluation of in vitro test systems in the clinical laboratory. In addition, the drug-bug work continued with evaluation of new antifungal agents and antibacterial agents. The topic of antimicrobial resistance became very popular in the 1990s, and the author's microbiology group at Iowa has been in the thick of this field of investigation. The close collaboration between clinical microbiology and hospital epidemiology is one that should be sought out by all concerned. From the perspective of the clinical microbiology laboratory, one can become involved in all of the most interesting infectious disease cases. Problems in diagnosis and control of infectious diseases provide a never-ending array of material for investigation and publication. Applied research in this area invariably leads to improvements in how the clinical laboratory can serve its clients and, in many cases, can serve as a springboard to more basic investigation.

Citation: Atlas R. 2000. Discovering What You Do and Don't Want, p 88-93. In Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch12
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Discovering What You Do and Don't Want
Citation: Atlas R. 2000. Discovering What You Do and Don't Want, p 88-93. In Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch12
/content/10.1128/9781555818128.chap12.fig-pg92-1
Figure 1
10.1128/9781555818128/fig-pg92-1_thmb.gif
10.1128/9781555818128/fig-pg92-1.gif
Image of Figure 1
Figure 1

Citation: Atlas R. 2000. Discovering What You Do and Don't Want, p 88-93. In Many Faces, Many Microbes. ASM Press, Washington, DC. doi: 10.1128/9781555818128.ch12
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555818128.chap12
1. Jones, R. N.,, D. M. Johnson,, M. E. Erwin,, M. L. Beach,, D. J. Biedenbach,, and M. A. Pfaller. 1999. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group. Diagn. Microbiol. Infect. Dis. 34: 91– 98.
2. Pfaller, M. A.,, R. N. Jones,, G. V. Doern,, H. S. Sader,, K. C. Kugler,, and M. L. Beach. 1999. Survey of bloodstream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn. Microbiol. Infect. Dis. 33: 283– 297.
3. Seguin, J. C.,, R. D. Walker,, J. P. Caron,, W. E. Kloos,, C. G. George,, R. J. Hollis,, R. N. Jones,, and M. A. Pfaller. 1999. Methicillin-resistant Staphylococcus aureus outbreak in a veterinary teaching hospital: Potential human-to-animal transmission. J. Clin. Microbiol. 37: 1459– 1463.
4. Pfaller, M. A.,, J. Zhang,, S. A. Messer,, M. E. Brandt,, R. A. Hajjeh,, C. J. Jessup,, M. Tumberland,, E. K. Mbidde,, and M. A. Ghannoum. 1999. In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob. Agents Chemother. 43: 169– 171.
5. Klepser, M. E.,, R. E. Lewis,, and M. A. Pfaller. 1998. Therapy of Candida infections: Susceptibility testing, resistance, and therapeutic options. Ann. Pharmacother. 32: 1353– 1361.
6. Wendt, C.,, S. A. Messer,, R. J. Hollis,, M. A. Pfaller,, and L. A. Herwaldt. 1998. Epidemiology of polyclonal gram-negative bacteremia. Diagn. Microbiol. Infect. Dis. 32: 9– 13.
7. Pfaller, M. A.,, S. R. Lockhart,, C. Pujol,, J. A. Swails-Wenger,, S. A. Messer,, M. B. Edmond,, R. N. Jones,, R. P. Wenze,, and D. R. Soli. 1998. Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates. J. Clin. Microbiol. 36: 1518– 1529.
8. Jones, R. N.,, and M. A. Pfaller. 1998. Bacterial resistance: A worldwide problem. Diagn. Microbiol. Infect. Dis. 31: 379– 388.
9. Wasilauskas, B.,, R. Gay,, P. Zwadyk,, M. Pfaller,, and F. Koontz. 1987. Multicenter comparison of MicroScan and BACTEC blood culture systems. J. Clin. Microbiol. 25: 2355– 2358.
10. Pfaller, M.,, B. Ringenberg,, L. Rames,, J. Hegeman,, and F. Koontz. 1987. The usefulness of screening tests for pyuria in combination with culture in the diagnosis of urinary tract infection. Diagn. Microbiol. Infect. Dis. 6: 207– 215.

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error